Category Archives: Health & Fitness Press Release

Digital Therapeutics Market Trends, Size, Forecast to 2023

The global digital therapeutics market is witnessing considerable growth due to increasing prevalence of chronic diseases and lifestyle associated diseases, growing geriatric population, need to control healthcare cost, and technological advancement. Moreover, increasing focus on preventive healthcare and increase in venture capital investment are supporting the growth of the market. The benefits of digital therapeutics such as improved drug adherence, ability to induce behavioral changes and patient convenience across the globe is also driving the growth of the market. Based on type of application, the market for preventive application segment is expected to grow at the faster rate during the forecast period, due to increasing government initiatives to increase preventive healthcare.

Overall Herbal Supplements Market is foreseen to create at CAGR over 5.6% post 2023

Market Research Future adds new report of “Global Herbal Supplements Market Research Report- Forecast to 2023” it contains Company information, geographical data and Table of Content

Key Players

The key players profiled in the Global Herbal Supplements Market are

  • Archer-Daniels-Midland Co. (U.S.)
  • Herbalife International of America, Inc. (U.S.)
  • Glanbia PLC (Ireland)
  • Ricola (Switzerland)
  • NBTY (U.S.)
  • Blackmores Limited (Australia)
  • Naturalife Asia Co. Ltd. (Seoul, Korea)

Intended Audience 

  • Herbal Supplements manufacturers
  • Pharmaceutical Industry
  • Agriculture Industry
  • Retailers and wholesalers
  • Traders, importers and exporters

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/3231

Market Segments:

Global Neuropsychiatric Disorders and Treatment Market – Strategy Resources, Manufacturers, Supply and Forecasts 2023

Market Scenario:
Neuropsychiatric is the mental disorder occur due to disturbance in the function of cerebral system. Mania and hallucination are some of the major neuropsychiatric diseases. Neuropsychiatric diseases occur at any age but the paediatric neuropsychiatry is getting a huge demand due to increasing number of infants, children and adolescents suffering from neuropsychiatric diseases. Increasing prevalence of different neuropsychiatric diseases across the globe is the major driving factor for the growth of the market. While long term treatment and lack of clinical trial data for neuropsychiatric diseases may hamper the growth of the market.

Global neuropsychiatric disorders and treatment market is expected to grow at a CAGR of 6.2% during forecasted period.

Global Antimalarial Medication Market Size, Status, Analysis and 2017-2022 Forecast Report

In this report, the Global Antimalarial Medication Market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Antimalarial Medication in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Antimalarial Medication market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
GlaxoSmithKline Plc
Ranbaxy Laboratories
Zydus Cadila
Alvizia Health Care
Bayer AG
Pfizer, Inc.
Ipca Laboratories Ltd
Merck KGaA
F. Hoffmann-La Roche AG
Novartis AG

Global Gastrointestinal Cancer Drug Market 2017 Technology, New Innovations, Future Guidelines, Key Players, Trends and Forecast 2022

In this report, the Global Gastrointestinal Cancer Drug Market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Gastrointestinal Cancer Drug in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India

Global Oncology Drugs Market (Oral Therapy and Injectable Therapy) Industry Analysis, Share, Growth, Trends and Forecast from 2017-2022

In this report, the Global Oncology Drugs Market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Oncology Drugs in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India

Global Desloratadine Sales (Injection and Freeze-dried powder) Market – United States Industry Size, Share, Analysis, Trend & Forecast 2017-2022

In this report, the Global Desloratadine Market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Desloratadine for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Domperidone Sales Market Report 2017

In this report, the Global Domperidone Market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Domperidone for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Endocrinology Drugs Sales Market Report 2017 Size, Share, Growth, Industry Demand, Forecast, Application Analysis To 2022

In this report, the Global Endocrinology Drugs Market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Endocrinology Drugs for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Designed by CyFocus.com
Powered by CyFocus.net